A Wide portfolio including a niche in hormonal and respiratory
325 SKUs mainly in chronic disease areas; 300 SKUs in the pipeline
A portfolio spanning 15 TAs, in particular female health/fertility, cardiovascular, urology, neuroscience, gastroenterology, etc.
Niche in novel, high-complexity products (in particular hormonal, respiratory)
Why partner with Marcyrl
Wide portfolio including niche in hormonal and respiratory products
Top-notch R&D and manufacturing capabilities with EU GMP-certified facilities
Cost competitiveness built on
world-class procurement and lean operations – Track record of
effective cost containment despite sharp currency devaluation
2017-2021; Leadership in the tender market (11% of sales in 2021)
Why partner with Marcyrl
Track record of registering and commercializing in export markets
Existing export footprint
in 23 countries outside of Egypt
107 successful registrations in export markets,
106 products under registration
Why partner with Marcyrl
Strong management team, backed by leading institutional investors
Experienced management with diverse expertise
Entry of DPI and Amethis in 2023
- combined AUM of USD 3.6 billion,
Africa focused with strong pharma exposure
How We Could Work Together
In-licensing
we provide access to Innovation, risk Mitigation, cost Efficiency, strategic fit, revenue generation, and time to market.
Niche in novel, high-complexity products (in particular hormonal, respiratory)
How We Could Work Together
Out-licensing
we provide revenue generation, resource allocation, global reach, risk sharing, access to expertise, Portfolio management, and Strategic Alliances
How We Could Work Together
CDMO (Contract Development and Manufacturing Organization)
we provide comprehensive services to pharmaceutical companies. These services span the development, manufacturing, and sometimes even the packaging and distribution of drug products. We are valuable partners for pharmaceutical companies, offering expertise and resources that can enhance efficiency, reduce costs, and accelerate time to market.
How We Could Work Together
CMO (Contract Manufacturing Organization)
we provide manufacturing services to pharmaceutical companies on a contract basis. We are specialized firms that offer expertise and facilities for producing finished drug products. We enable pharmaceutical companies to optimize their resources and focus on innovation
Let’s work together
Export Capabilites
Marcyrl Pharmaceutical Industries, an Egyptian pharmaceutical manufacturer, has secured investment from Development Partners International (DPI) and Amethis. They focus on specialty generics, to improve access to critical care drugs across Africa. Marcyrl’s growth includes expanding its product portfolio and addressing the demand for affordable specialty generics in Africa. The investment underscores the significance of the pharmaceutical sector and Marcyrl’s commitment to bridging healthcare gaps in the continent.
Capitalizing on our EU-approved GMP sites, Marcyrl Pharmaceutical Industries is exporting a wide range portfolio of medicines to 23 export markets including GCC, LEVANT, and AFRICA
Our ambitious plan to expand our export business in Africa, CIS, GCC, and LATAM.
